Impact of dopamine supersensitivity psychosis in treatment-resistant schizophrenia: An analysis of multi-factors predicting long-term prognosis

Schizophrenia Research
Hiroshi YamanakaMasaomi Iyo

Abstract

Although a variety of factors are known to be significantly related to poor prognosis in schizophrenia, their interactions remain unclear. Dopamine supersensitivity psychosis (DSP) is a clinical concept related to long-term pharmacotherapy and could be one of the key factors contributing to the development of treatment-resistant schizophrenia (TRS). The present study aims to explore the effect of DSP on progression to TRS. Two-hundreds and sixty-five patients were classified into either a TRS or Non-TRS group based on retrospective survey and direct interview. The key factors related to prognosis, including the presence or absence of DSP episodes, were extracted, and each factor was compared between the two groups. All parameters except for the duration of untreated psychosis (DUP) were significantly worse in the TRS group compared to the Non-TRS group. In particular, the TRS group presented with a significantly higher rate of DSP episodes than the Non-TRS group. Regression analysis supported the notion that DSP plays a pivotal role in the development of TRS. In addition, deficit syndrome was suggested to be a diagnostic subcategory of TRS. Our data confirmed that the key predicting factors of poor prognosis which have been est...Continue Reading

References

Apr 1, 1992·The Journal of Nervous and Mental Disease·B KirkpatrickR W Buchanan
Jul 1, 1987·The American Journal of Psychiatry·R S KeefeK L Davis
Jan 1, 1982·Schizophrenia Bulletin·H E Cannon-SpoorR J Wyatt
Aug 1, 1995·Psychiatric Services : a Journal of the American Psychiatric Association·M G Juarez-ReyesW A Hargreaves
Jan 1, 1996·Schizophrenia Bulletin·P D McGorryH J Jackson
Apr 1, 1997·The American Journal of Psychiatry·H Y MeltzerP A Thompson
Apr 29, 1998·Journal of Clinical Psychopharmacology·R M Murray, J Van Os
Nov 5, 2003·The American Journal of Psychiatry·Christoph U CorrellJohn M Kane
May 3, 2005·The American Journal of Psychiatry·Shitij KapurBarry Jones
Jan 2, 2007·The Journal of Clinical Psychiatry·Robin EmsleyH Jadri Turner
Dec 20, 2008·Schizophrenia Bulletin·Gregory P StraussCherise Rosen
Feb 4, 2009·Psychological Medicine·C WhiteS Lewis
Nov 6, 2009·Schizophrenia Research·Alex S CohenKyle S Minor
Jan 31, 2012·Schizophrenia Research·Julie EvensenThomas McGlashan
Jul 19, 2013·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Philip Seeman
Feb 1, 2012·Therapeutic Advances in Psychopharmacology·Paul FallonBill Deakin
Oct 17, 2013·Progress in Neuro-psychopharmacology & Biological Psychiatry·Mary V Seeman, Philip Seeman

❮ Previous
Next ❯

Citations

Sep 20, 2017·Journal of Psychopharmacology·Yusuke NakataMasaomi Iyo
Jun 2, 2018·World Psychiatry : Official Journal of the World Psychiatric Association (WPA)·Christoph U CorrellJohn M Kane
Mar 30, 2017·Therapeutic Advances in Psychopharmacology·Mina FukaiYoshio Minabe

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.